Delight working with @a_blasimme on Dec issue of @JournalofEthics #CRISPR#genomeediting
Contributions span patient monitoring, public engagement, politics, professional risk management, patents, and prioritizing women’s health.
Hope you enjoy reading!
https://t.co/tZyhfLbBnr
The #zebrafish Nod-like receptor genes are mixed and matched between individuals like "traditional" allogeneic MHC molecules. Cool genomic discovery by @SeanCMcConnell et al https://t.co/Dkac1BcWOw
So pleased to announce registration is now open for our #pharmacogenomics summit series (free), starting Feb. 9.
Learn from leading experts about the evidence base, best practices for clinical adoption, and health equity.
https://t.co/AJqPBqMOkm
@AmerMedicalAssn@ASHPOfficial
New! Consumer genomics has evolved considerably over the last decade. To learn more about the current landscape, read our proceedings: https://t.co/sWKxwUteQi
Discuss challenges and opportunities in using #DigitalHealthTech to improve success rates in drug trials at our virtual workshop on 3/24 @NASEM_Health. Sign up today: https://t.co/ENp4TRCF3a #DrugForum#GenomicsRT
Reports from large somatic cancer panels contain valuable information, but can be challenging to interpret.
Check out our module in collaboration with @AmerMedicalAssn@ScrippsRTI
👇
https://t.co/M4bSdXV05t
Register now for @theNAMedicine symposium exploring 3 priorities for the future of health: vaccines & immunology, digital innovation, & climate change. April 7 in San Francisco or live webcast: https://t.co/o6HMpIhxrZ #50impacts
Factors shaping #postdoc career interests, including attrition of female and underrepresented groups in the biomedical sciences - For #STEM#diversity#MentoringMatters
https://t.co/Vuou4s62ZF
Questions about the novel coronavirus?
Tune into the AMA Facebook page today at 11 AM CST for a Q&A session to discuss what physicians need to know.
https://t.co/570LWPGvfd
For more than half a century, scientists have known the cause of sickle cell disease, a single mutation in a gene. Millions of people are affected globally, a vast majority of them Africans. Has gene therapy finally arrived? @ginakolata in @nytimes https://t.co/kwDjA441Tb
My favorite papers challenge biomedical dogma. Here's my summary of the ones in 2019 that provided evidentiary shakeups (2nd annual list)
[let me know the ones I missed]
The December 2019 issue of the #AMA Journal of #Ethics (we publish monthly) is available for free at our site! Read "Governing Human Genome Editing" here: https://t.co/neu15scOez
Gene edits made to babies' genomes will impart changes that last their entire lives. How should "CRISPRed" babies be monitored? https://t.co/jUAUugELC4
"Only inclusive deliberation can confer democratic legitimacy on decisions that can affect the future of humanity." - @a_blasimme on the importance of including the public in genome editing governance deliberations. https://t.co/qOE68DMphR
On the first episode of the #OmicsXchange - GA4GH's new podcast series - we spoke with Dr. Bartha Knoppers (@genomics_policy) on how Article 27 from the Universal Declaration of Human Rights is vital to genomic data sharing: https://t.co/Lo5KcgBFk5 #InternationalHumanRightsDay
Read our December issue, packed full of expert analysis and commentary on ethical, clinical, and legal challenges around human genome editing, all for free! Think of it like an early Christmas present. #CRISPR#ethics#geneediting https://t.co/OAwsUCFwa3